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Abstract The A222 V substitution in the human MTHFR
gene product (5,10-methylenetetrahydrofolate reductase) is
responsible for a decreased activity of this enzyme. This
may cause an increased homocysteine level, considered as a
risk factor for arteriosclerosis and stroke. The bacterial homo-
logue of the human enzyme, MetF, has been found to be a
useful model in genetic and biochemical studies. The similar-
ity of Escherichia coli MetF and human MTHFR proteins is
so high that particular mutations in the corresponding human
gene can be reflected by the bacterial mutants. For example,
the A222 V substitution in MTHFR (caused by the C667T
substitution in the MTHFR gene) can be ascribed to the
A117 V substitution in MetF. Here, it is reported that a
temperature-sensitive MetF117 (A117 V) protein can be par-
tially protected from a thermal inactivation by the heat shock
proteins from the Hsp70/100 systems. Moreover, activity of
the thermally denatured enzyme can be partially restored by
the same heat shock proteins. High temperature protein G
(HtpG) had no effect on MetF117 activity in both experimen-
tal systems. The presented results indicate that functions of
heat shock proteins may be required for maintenance of the
MetF117 function. This may have implications for the mech-
anisms of arteriosclerosis and stroke, especially in the light of
previous findings that the A222 V MTHFR polymorphism
may be a risk factor for stroke, as well as recently published
results which demonstrated the increased levels of antibodies
against heat shock proteins in stroke patients.
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Introduction
5,10-Methylenetetrahydrofolate reductase (EC 1.5.1.20) is
encoded in humans by the MTHFR gene. This enzyme is
involved in homocysteine metabolism (presented schemati-
cally in Fig. 1), as it catalyses the conversion of 5,10-methy-
lenetetrahydrofolate to 5-methyltetrahydrofolate, which
serves as a methyl donor in the remethylation of homocysteine
tomethionine (Bailey and Gregory 1999). Therefore, dysfunc-
tion or decreased activity of theMTHFR gene product leads to
increased levels of homocysteine. Hyperhomocysteinemia
causes toxicity to vascular and nervous systems (Perła-Kaján
et al. 2007). Thus, this metabolic defect is considered a risk
factor for various diseases, including stroke, minimal cogni-
tive impairment, dementia, Parkinson disease, multiple scle-
rosis, epilepsy, and eclampsia (for reviews see Ansari et al.
2014; Keshteli et al. 2015).
Among diseases for which hyperhomocysteinemia is a risk
factor, stroke is one of the most severe disorders (for a review,
see Banecka-Majkutewicz et al. 2012). Increased levels of
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homocysteine was correlated with the incidence of stroke in as
various populations as those from Poland (Sawuła et al. 2009)
and Karachi (Sadiq et al. 2014). Recent studies indicate that in
stroke patients there are increased levels of antibodies against
heat shock proteins (Hsps) (Banecka-Majkutewicz et al.
2014). Such results might suggest an essential role for Hsp
deficiency in development of the atherosclerosis and stroke.
However, the exact role of Hsps in putative stroke prevention
remains unclear. Some light on this problem was shed by
studies demonstrating that the Hsp70/100 system has a role
in maintaining activity of Escherichia coli MetH protein, a
homologue of human methionine synthase, another enzyme
involved in homocysteine metabolism (Grabowski et al. 2012;
Fig. 1). Since there is a high similarity between E. coliMetH
and human methionine synthase, one might suggest that in-
creased levels of anti-Hsps antibodies might reduce the effi-
ciency of the chaperone systems, thus interfering with the
homocysteine metabolism.
Continuing this line of studies, we aimed to investigate a
potential role for Hsps in modulation of activity of the E. coli
MetF protein, a homologue of the human 5,10-methylenetet-
rahydrofolate reductase (MTHFR). The level of similarity be-
tween these enzymes is so high that particular amino acid
residues in MetF can be ascribed to their counterparts in
MTHFR. For example A117 in MetF corresponds to A222
in MTHFR (Guenther et al. 1999). On the basis of structural
and biochemical properties of the mutated form of MetF
(A117 V), a specific mechanism leading to decreased activity
and increased thermolability of the A222 V variant of
MTHFR has been suggested (Guenther et al. 1999). The
A222 V substitution is an effect of a common polymorphism
in the MTHFR gene, the C to T transition at nucleotide
position 677 (Ueland et al. 2001). It was demonstrated that
human homozygotes with two 677 T alleles have a high con-
centration of plasma homocysteine, while heterozygotes may
reveal moderate hyperhomocysteinemia, relative to 667C ho-
mozygotes (Kluijtmans and Whitehead 2001). Subsequent
studies indicated that the E. coli system, in which production
of wild-type or the A117 V variant of the MetF enzyme or
both is allowed, can efficiently mimic human wild-type ho-
mozygote, A222 V homozygote or heterozygote, respectively,
in activities of methylenetetrahydrofolate reductase
(Jakobkiewicz-Banecka et al. 2005). This indicated that the
E. coliMetF protein can be successfully employed as a model
in studies on the human MTHFR enzyme, and has opened
new possibilities of more detailed investigations, including
aspects related to human diseases. In fact, there is no doubt
that experiments with bacterial systems are significantly sim-
pler and easier to work with than studies on human subjects,
thus, the bacterial model of the human enzyme is particularly
useful. It was demonstrated that among other phenotypes,
bacteria expressing the metF117 allele produces a
thermosensitive 117 V variant of MetF which biochemically
and physiologically corresponds to a thermolabile A222 V
variant of human MTHFR (Jakobkiewicz-Banecka et al.
2005). Therefore, in this work, we aimed to use the
MetF117 protein to test whether Hsps can contribute to the




Overproduction of proteins was performed in E. coli
BL21(DE3) RIL in TB medium with 5 M FAD. The wild-
type MetF protein was purified as described previously
(Sheppard et al. 1999). The 117 variant of MetF was purified
analogously as the wild-type enzyme, but all buffers used for
purification of MetF117 were supplemented with 5 μM FAD.
DnaK, GrpE, DnaJ, ClpB and HtpG were overproduced
and purified according to the previously published
methods (Banecki and Zylicz 1996; Banecki et al. 1996;
Spence and Georgopoulos 1989; Woo et al. 1992;
Wawrzynów et al. 1995).
Determination of methylenetetrahydrofolate reductase
activity
Determination of methylenetetrahydrofolate reductase was
performed as described previously (Sheppard et al. 1999),
by measuring a decrease in absorbance of NADH, consumed
during the reaction. The reaction mixture consisted of 50 mM
phosphate buffer containing 10 % glycerol, 0.3 mM EDTA,
Fig. 1 Homocysteine metabolic pathway diagram detailing the
human and bacterial methylenetetrahydrofolate reductase. MTHFR
– human methylenetetrahydrofolate reductase, MetF – E.coli
methylenetetrahydrofolate reductase, MS – methionine synthase,
MetH – E.coli methionine synthase
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400 μM NADH, and 1.4 mM menadione (vitamin K3 was
used as an artificial substrate for MetF). The activity of MetF
was determined bymeasurement of the kinetics of the reaction
at 37 °C. The reaction mixture was prepared without the en-
zyme, and incubated for 5 min. Following reaction initiation
by the addition of 0.3 μM enzyme, the measurement was
carried out for 30 min, by monitoring the absorbance at a
wavelength of 340 nm.
Hsps protection of MetF117 from temperature-mediated
denaturation
MetF (at final concentration of 0.3 μM) was pre-incubated in
the presence of 50 mM phosphate buffer (pH 7.2) containing
10 % glycerol, 0.3 mM EDTA, 50 mM NaCl, 20 mM KCl,
20 mM MgCl2, and in the presence of DnaK, DnaJ, GrpE,
ClpB (the Hsp 70/100 system) or HtpG, and 5 mM ATP. The
concentrations of heat shock proteins were 3.7 μM, 1.4 μM,
0.36μM, 1.5 μM, respectively for Hsp70/100, and 3.6 μM for
HtpG. The incubation was carried out for 15 min at 50 °C.
Finally, the samples were subjected to the MetF activity test.
Reactivation of thermally-denatured MetF117 by Hsps
MetF (at final concentration of 0.3 μM) was thermally
inactivated by 15 min incubation at 50 °C in the presence of
50 mM phosphate buffer (pH = 7.2) containing 10% glycerol,
0.3 mM EDTA, 50 mM NaCl, 20 mM KCl, and 20 mM
MgCl2. Following the incubation, the enzyme was renatured
in the presence of Hsp 70/100 or HtpG at the concentrations
indicated in the preceding subsection. The renaturation was
carried out for 45 min at 20 °C. Finally, the samples were
subjected to the MetF activity test.
Statistical analysis
Statistical analysis was performed using T-test. A p val-
ue < 0.05 was considered to indicate statistical significance.
Each experiment was repeated three times. All data were cal-
culated with Statistica 12 software (StatSoft).
Results
Wild-type and the 117 V variant of E. coli methylenetetrahy-
drofolate reductase, MetF and MetF117, respectively, were
purified from bacteria overexpressing corresponding metF al-
leles from a plasmid. We found that both variants of the en-
zyme had similar activities at 37 °C (Fig. 2a).
To test effects of an increased temperature onMetF activity,
the reaction mixtures were incubated at various temperatures.
Significantly higher thermosensitivity of MetF117, relative to
the wild-type enzyme, was observed (Fig. 2b). For further
experiments, temperature 50 °C was chosen, at which the
difference between both variants of the enzyme was the most
pronounced.
We found that the proteins from the Hsp70/100 system,
DnaK, DnaJ, GroEL, ClpB, could partially protect the
MetF117 protein against thermal denaturation (Fig. 3a). The
mutated enzyme revealed a significantly higher activity at
50 °C in the presence of the Hsp70/100 systems than in the
absence of Hsps (p = 0.0012; t-test). HtpG had no significant
effect on MetF117 activity (p = 0.4667; t-test).
When testing a reactivation of the previously thermally-
denatured MetF117, we found that the Hsp70/100 system is
able to partially recover the enzyme activity (Fig. 3b;
p = 0.015; t-test). Again, HtpG was unable to restore
MetF117 activity (p = 0.5; t-test). Therefore, we conclude that
Hsps can both partially protect and rescue MetF117 activity at
elevated temperature.
Discussion
The results presented in this report indicate that Hsps have
important roles in activation of the mutated MetF variant.
The in vitro experiments were performed at 50 °C to demon-
strate the most pronounced effects which occurred at an ex-
tremely high temperature relative to physiological conditions.
However, most probably, similar functions of the Hsp70/100
Fig. 2 The reaction kinetics of wild-type MetF and MetF117 at 37 °C
(panel a) and at 50 °C (panel b). The enzymatic activity is reflected by a
decrease in NADH absorbance, as this compound is consumed during the
reaction
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system may be important at physiological temperatures in
living organisms. This assumption is based on the fact that at
higher temperature the negative effects on the protein function
should be more pronounced than at a lower one, thus, their
correction is more difficult. Moreover, the Hsp70/100 system
should work more efficiently under physiological conditions
than at the extremely high temperature. Hence, if the system
works under drastic conditions, it is likely that it also works in
the living organism. Unfortunately, in the artificial in vitro
system, the easily detected and unequivocally measurable ef-
fects occurred only at high temperature. On the other hand,
this system provided a possibility to obtain a clear response to
the asked question, due to its simplicity and the presence of
only those factors which activities were investigated.
Because of the high similarity, both structural (Guenther et al.
1999) and functional (Jakobkiewicz-Banecka et al. 2005), be-
tween bacterial MetF and human MTHFR proteins, and their
thermosensitive variants 117 Vand 222 V, respectively, we sug-
gest that some implications can be proposed for the human
organism. The 667 Tallele of theMTHFR gene has been shown
to cause a decreased activity of the encoded enzyme, and an
increased levels of homocysteine, even if occurring in the
heterozygotic state (Kluijtmans and Whitehead 2001).
Moreover, hyperhomocysteinemia was considered a risk factor
for stroke (Sawuła et al. 2009; Ansari et al. 2014; Sadiq et al.
2014). Nevertheless, it is obvious that not all persons having an
increased plasma level of homocysteine suffer from stroke.
Therefore, other factors, agents and/or conditions must also be
involved in the mechanism of an increased risk of this disorder
in persons with hyperhomocysteinemia. One of them may be
Hsps, as these proteins can modulate activity of methylenetetra-
hydrofolate reductase, and particularly its thermolabille form.
It is tempting to speculate that if the Hsp70/100 system is
fully functional, the activity of the thermolabille MTHFR is
sufficient to keep the homocysteine level low enough to avoid
an increased risk for stroke. However, it was reported that in
stroke patients, as well as patients in whom stroke occurred in
the past, there are increased levels of anti-Hsps antibodies
(Banecka-Majkutewicz et al. 2014). These antibodies could
inactivate Hsps, resulting in less efficient protection or reacti-
vation of the mutant MTHFR, and in turn, increased levels of
homocysteine, leading to a high risk for stroke. Along to this
hypothesis, it is worth reminding that the Hsp70/100 system
can also maintain appropriate activity of methionine synthase
(Grabowski et al. 2012), and dysfunction of this enzyme can
also cause hyperhomocysteinemia (Matthews and Elmore
2007). Intriguingly, HtpG had no effect on protection or rena-
turation ofMetF117, thus, these reactions appear to be specific
to the Hsp70/100 system. At the current stage of our knowl-
edge, the reason and mechanism of such specificity are un-
clear and require further extensive studies, which extend be-
yond the aims of this study. We are aware that such a proposal
requires experimental and clinical verifications in studies on
the human biological material, nevertheless, this report indi-
cates a possibility bywhich different factors might interplay in
the way of stroke occurrence.
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